GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review

GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the treatment of spasticity due to multiple sclerosis. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. GW Pharmaceuticals is also developing products for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis, infantile spasms, epilepsy syndrome, glioma, schizophrenia, autism among others. The company has subsidiaries in Australia, the US, England and Wales, and Guernsey. GW Pharmaceuticals is headquartered in Cambridgeshire, the UK.

GW Pharmaceuticals Plc Key Recent Developments

Nov 27,2018: GW Pharmaceuticals announces fiscal fourth quarter and year-end 2018 financial results and operational progress
Nov 01,2018: EPIDIOLEX® (cannabidiol) Oral Solution – the First FDA-approved Plant-derived Cannabinoid Medicine – Now Available by Prescription in the U.S.
Oct 22,2018: Food and Drug Administration (FDA) Approval of GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences EPIDIOLEX (cannabidiol) CV Marks First Drug Approval and Scheduling Decision Supported by Analgesic Solutions MADDERS System
Aug 28,2018: GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology
Aug 07,2018: GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 

List of Tables 5
List of Figures 5
Section 1 - About the Company 6
GW Pharmaceuticals Plc - Key Facts 6
GW Pharmaceuticals Plc - Key Employees 7
GW Pharmaceuticals Plc - Key Employee Biographies 8
GW Pharmaceuticals Plc - Major Products and Services 9
GW Pharmaceuticals Plc - History 10
GW Pharmaceuticals Plc - Company Statement 13
GW Pharmaceuticals Plc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 16
Company Overview 16
GW Pharmaceuticals Plc - Business Description 17
Geographical Segment: Asia/Other 17
Performance 17
Geographical Segment: Canada 17
Performance 17
Geographical Segment: Europe (Excluding the UK) 17
Performance 17
Geographical Segment: The UK 17
Performance 17
Geographical Segment: The US 18
Performance 18
R&D Overview 18
GW Pharmaceuticals Plc - Corporate Strategy 19
GW Pharmaceuticals Plc - SWOT Analysis 20
SWOT Analysis - Overview 20
GW Pharmaceuticals Plc - Strengths 20
GW Pharmaceuticals Plc - Weaknesses 21
GW Pharmaceuticals Plc - Opportunities 22
GW Pharmaceuticals Plc - Threats 23
GW Pharmaceuticals Plc - Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios - Capital Market Ratios 25
Financial Ratios - Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios - Interim Ratios 30
Financial Ratios - Ratio Charts 31
Section 4 – Company’s Lifesciences Financial Deals and Alliances 32
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 32
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 33
GW Pharmaceuticals Plc, Recent Deals Summary 34
Section 5 – Company’s Recent Developments 35
Nov 01, 2018: EPIDIOLEX® (cannabidiol) Oral Solution – the First FDA-approved Plant-derived Cannabinoid Medicine – Now Available by Prescription in the U.S. 35
Oct 22, 2018: Food and Drug Administration (FDA) Approval of GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences EPIDIOLEX (cannabidiol) CV Marks First Drug Approval and Scheduling Decision Supported by Analgesic Solutions MADDERS System 38
Aug 07, 2018: GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress 39
Aug 02, 2018: Certara Software or Services supported 95% of the US FDA novel drug approvals in first half of 2018 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46
 


List Of Tables

GW Pharmaceuticals Plc, Key Facts 6
GW Pharmaceuticals Plc, Key Employees 7
GW Pharmaceuticals Plc, Key Employee Biographies 8
GW Pharmaceuticals Plc, Major Products and Services 9
GW Pharmaceuticals Plc, History 10
GW Pharmaceuticals Plc, Other Locations 15
GW Pharmaceuticals Plc, Subsidiaries 15
GW Pharmaceuticals Plc, Key Competitors 24
GW Pharmaceuticals Plc, Ratios based on current share price 25
GW Pharmaceuticals Plc, Annual Ratios 26
GW Pharmaceuticals Plc, Annual Ratios (Cont...1) 27
GW Pharmaceuticals Plc, Annual Ratios (Cont...2) 28
GW Pharmaceuticals Plc, Interim Ratios 30
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 32
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 33
GW Pharmaceuticals Plc, Recent Deals Summary 34
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45
 


List Of Figures

GW Pharmaceuticals Plc, Performance Chart (2013 - 2017) 29
GW Pharmaceuticals Plc, Ratio Charts 31
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 32
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 33
 


GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) - Drugs in Development, 2021

GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) - Drugs in Development, 2021GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) - Drugs in Development, 2021 provides

USD 3000 View Report

GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review

GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review market research report available in single user pdf license with Aarkstore Enterprise at USD 125

USD 125 View Report

GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review

GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review market research report available in single user pdf license with Aarkstore Enterprise at USD 125

USD 125 View Report

Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review

Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available